369 related articles for article (PubMed ID: 30654362)
1. Efficacy and Safety of Topical 3% Diquafosol Ophthalmic Solution for the Treatment of Multifactorial Dry Eye Disease: Meta-Analysis of Randomized Clinical Trials.
Nam K; Kim HJ; Yoo A
Ophthalmic Res; 2019; 61(4):188-198. PubMed ID: 30654362
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of topical diquafosol for the treatment of dry eye disease: An updated meta-analysis of randomized controlled trials.
Liu S; Yang G; Li Q; Tang S
Indian J Ophthalmol; 2023 Apr; 71(4):1304-1315. PubMed ID: 37026262
[TBL] [Abstract][Full Text] [Related]
3. Additive Effect of preservative-free sodium hyaluronate 0.1% in treatment of dry eye syndrome with diquafosol 3% eye drops.
Hwang HS; Sung YM; Lee WS; Kim EC
Cornea; 2014 Sep; 33(9):935-41. PubMed ID: 25055152
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Topical Diquafosol Tetrasodium 3% on Dry Eye After Cataract Surgery.
Baek J; Doh SH; Chung SK
Curr Eye Res; 2016 Oct; 41(10):1281-1285. PubMed ID: 27049809
[TBL] [Abstract][Full Text] [Related]
5. Long-term rebamipide and diquafosol in two cases of immune-mediated dry eye.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Saijo-Ban Y; Yaguchi S; Mukai S; Kawakita T; Simmura S; Tsubota K
Optom Vis Sci; 2015 Apr; 92(4 Suppl 1):S25-32. PubMed ID: 25785527
[TBL] [Abstract][Full Text] [Related]
6. Effects of Preservative-free 3% Diquafosol in Patients with Pre-existing Dry Eye Disease after Cataract Surgery: A Randomized Clinical Trial.
Jun I; Choi S; Lee GY; Choi YJ; Lee HK; Kim EK; Seo KY; Kim TI
Sci Rep; 2019 Sep; 9(1):12659. PubMed ID: 31477748
[TBL] [Abstract][Full Text] [Related]
7. Diquafosol sodium ophthalmic solution for the treatment of dry eye: clinical evaluation and biochemical analysis of tear composition.
Shigeyasu C; Yamada M; Akune Y; Tsubota K
Jpn J Ophthalmol; 2015 Nov; 59(6):415-20. PubMed ID: 26310103
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of diquafosol ophthalmic solution in patients with dry eye syndrome: a Japanese phase 2 clinical trial.
Matsumoto Y; Ohashi Y; Watanabe H; Tsubota K;
Ophthalmology; 2012 Oct; 119(10):1954-60. PubMed ID: 22739038
[TBL] [Abstract][Full Text] [Related]
9. Diquafosol ophthalmic solution 3 %: a review of its use in dry eye.
Keating GM
Drugs; 2015 May; 75(8):911-22. PubMed ID: 25968930
[TBL] [Abstract][Full Text] [Related]
10. Clinical Effects and Safety of 3% Diquafosol Ophthalmic Solution for Patients With Dry Eye After Cataract Surgery: A Randomized Controlled Trial.
Park DH; Chung JK; Seo DR; Lee SJ
Am J Ophthalmol; 2016 Mar; 163():122-131.e2. PubMed ID: 26685791
[TBL] [Abstract][Full Text] [Related]
11. Diquafosol ophthalmic solution for dry eye treatment.
Nakamura M; Imanaka T; Sakamoto A
Adv Ther; 2012 Jul; 29(7):579-89. PubMed ID: 22843206
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of topical diquafosol ophthalmic solution for treatment of dry eye: a systematic review of randomized clinical trials.
Wu D; Chen WQ; Li R; Wang Y
Cornea; 2015 Jun; 34(6):644-50. PubMed ID: 25909234
[TBL] [Abstract][Full Text] [Related]
13. Effects of Diquafosol Ophthalmic Solution on Quality of Life in Dry Eye Assessed Using the Dry Eye-Related Quality-of-Life Score Questionnaire: Effectiveness in Patients While Reading and Using Visual Display Terminals.
Utsunomiya T; Kawahara A; Hanada K; Yoshida A
Cornea; 2017 Aug; 36(8):908-914. PubMed ID: 28542084
[TBL] [Abstract][Full Text] [Related]
14. Three percent diquafosol ophthalmic solution as an additional therapy to existing artificial tears with steroids for dry-eye patients with Sjögren's syndrome.
Yokoi N; Sonomura Y; Kato H; Komuro A; Kinoshita S
Eye (Lond); 2015 Sep; 29(9):1204-12. PubMed ID: 26160526
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of 3% diquafosol ophthalmic solution in patients with short tear film break-up time-type dry eye disease.
Mun Y; Kwon JW; Oh JY
BMC Ophthalmol; 2018 Sep; 18(1):237. PubMed ID: 30185156
[TBL] [Abstract][Full Text] [Related]
16. Double-masked, placebo-controlled safety and efficacy trial of diquafosol tetrasodium (INS365) ophthalmic solution for the treatment of dry eye.
Tauber J; Davitt WF; Bokosky JE; Nichols KK; Yerxa BR; Schaberg AE; LaVange LM; Mills-Wilson MC; Kellerman DJ
Cornea; 2004 Nov; 23(8):784-92. PubMed ID: 15502479
[TBL] [Abstract][Full Text] [Related]
17. A randomised, parallel-group comparison study of diquafosol ophthalmic solution in patients with dry eye in China and Singapore.
Gong L; Sun X; Ma Z; Wang Q; Xu X; Chen X; Shao Y; Yao K; Tang L; Gu Y; Yuan H; Chua WH; Chuan JC; Tong L
Br J Ophthalmol; 2015 Jul; 99(7):903-8. PubMed ID: 25631485
[TBL] [Abstract][Full Text] [Related]
18. The Efficacy of Diquafosol Ophthalmic Solution in Non-Sjögren and Sjögren Syndrome Dry Eye Patients Unresponsive to Artificial Tear.
Jeon HS; Hyon JY
J Ocul Pharmacol Ther; 2016 Sep; 32(7):463-8. PubMed ID: 27294831
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the efficacy between topical diquafosol and artificial tears in the treatment of dry eye following cataract surgery: A meta-analysis of randomized controlled trials.
Zhao X; Xia S; Chen Y
Medicine (Baltimore); 2017 Sep; 96(39):e8174. PubMed ID: 28953672
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Topical Diquafosol Tetrasodium Treatment of Dry Eye Disease Caused by Chronic Graft-Versus-Host Disease: A Retrospective Study.
Yamane M; Ogawa Y; Fukui M; Kamoi M; Uchino M; Saijo-Ban Y; Kozuki N; Mukai S; Mori T; Okamoto S; Tsubota K
Eye Contact Lens; 2018 Nov; 44 Suppl 2():S215-S220. PubMed ID: 29280750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
